Cargando…
The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model
BACKGROUND: The efficacy of current surgery and chemotherapy for triple negative breast cancer (TNBC) is limited due to heterogenous and immunosuppressive tumor microenvironment (TME). Tumor associated macrophages (TAMs), which are regarded as an M2 tumor-promoting phenotype, are crucial in the deve...
Autores principales: | Liu, Bichen, Huang, Jun, Xiao, Jiangming, Xu, Wenlong, Zhang, Hong, Yuan, Yuan, Yin, Yibing, Zhang, Xuemei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625220/ https://www.ncbi.nlm.nih.gov/pubmed/37925462 http://dx.doi.org/10.1186/s13578-023-01153-w |
Ejemplares similares
-
PepO and CppA modulate Streptococcus sanguinis susceptibility to complement immunity and virulence
por: Alves, Lívia A., et al.
Publicado: (2023) -
Streptococcus pneumoniae PepO promotes host anti-infection defense via autophagy in a Toll-like receptor 2/4 dependent manner
por: Shu, Zhaoche, et al.
Publicado: (2020) -
Streptococcus pneumoniae Endopeptidase O (PepO) Elicits a Strong Innate Immune Response in Mice via TLR2 and TLR4 Signaling Pathways
por: Zhang, Hong, et al.
Publicado: (2016) -
PepO is a target of the two-component systems VicRK and CovR required for systemic virulence of Streptococcus mutans
por: Alves, Lívia A., et al.
Publicado: (2020) -
In silico designing of a novel epitope-based candidate vaccine against Streptococcus pneumoniae with introduction of a new domain of PepO as adjuvant
por: Bahadori, Zohreh, et al.
Publicado: (2022)